89 related articles for article (PubMed ID: 7784091)
1. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu.
Xie Y; Li K; Hung MC
Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091
[TBL] [Abstract][Full Text] [Related]
2. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
Soler C; Alvarez CV; Beguinot L; Carpenter G
Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
[TBL] [Abstract][Full Text] [Related]
3. Collagen-homology domain 1 deletion mutant of Shc suppresses transformation mediated by neu through a MAPK-independent pathway.
Li K; Shao R; Hung MC
Oncogene; 1999 Apr; 18(16):2617-26. PubMed ID: 10353605
[TBL] [Abstract][Full Text] [Related]
4. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
Pei Z; Maloney JA; Yang L; Williamson JR
Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317
[TBL] [Abstract][Full Text] [Related]
5. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
6. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase.
Crowe AJ; McGlade J; Pawson T; Hayman MJ
Oncogene; 1994 Feb; 9(2):537-44. PubMed ID: 8290264
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
9. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
Rojas M; Yao S; Donahue JP; Lin YZ
Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
[TBL] [Abstract][Full Text] [Related]
10. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
[TBL] [Abstract][Full Text] [Related]
11. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
[TBL] [Abstract][Full Text] [Related]
12. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
[TBL] [Abstract][Full Text] [Related]
13. Constitutive phosphorylation of Shc proteins in human tumors.
Pelicci G; Lanfrancone L; Salcini AE; Romano A; Mele S; Grazia Borrello M; Segatto O; Di Fiore PP; Pelicci PG
Oncogene; 1995 Sep; 11(5):899-907. PubMed ID: 7675449
[TBL] [Abstract][Full Text] [Related]
14. Actinomycin D as a novel SH2 domain ligand inhibits Shc/Grb2 interaction in B104-1-1 (neu*-transformed NIH3T3) and SAA (hEGFR-overexpressed NIH3T3) cells.
Kim HK; Nam JY; Han MY; Lee EK; Choi JD; Bok SH; Kwon BM
FEBS Lett; 1999 Jun; 453(1-2):174-8. PubMed ID: 10403397
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu.
Xie Y; Pendergast AM; Hung MC
J Biol Chem; 1995 Dec; 270(51):30717-24. PubMed ID: 8530511
[TBL] [Abstract][Full Text] [Related]
16. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
17. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
[TBL] [Abstract][Full Text] [Related]
18. Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.
Verderame MF; Guan JL; Woods Ignatoski KM
Mol Biol Cell; 1995 Aug; 6(8):953-66. PubMed ID: 7579711
[TBL] [Abstract][Full Text] [Related]
19. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.
Dankort DL; Wang Z; Blackmore V; Moran MF; Muller WJ
Mol Cell Biol; 1997 Sep; 17(9):5410-25. PubMed ID: 9271418
[TBL] [Abstract][Full Text] [Related]
20. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation.
Ouwens DM; van der Zon GC; Pronk GJ; Bos JL; Möller W; Cheatham B; Kahn CR; Maassen JA
J Biol Chem; 1994 Dec; 269(52):33116-22. PubMed ID: 7806540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
